• English
  • Korean
  • Chinese
表紙
市場調査レポート - 232659

バイオシミラーの世界市場動向

Global Biosimilars Market 2014-2018

発行 Infiniti Research Limited (Technavio)
出版日 ページ情報 英文 106 Pages
電子版即納可
価格
バイオシミラーの世界市場動向 Global Biosimilars Market 2014-2018
出版日: 2014年02月14日 ページ情報: 英文 106 Pages
概要

世界におけるバイオシミラー市場は、2013年から2018年かけて27.58%のCAGRで拡大すると予測されています。多くのバイオ医薬品が特許満了を迎えることが、この成長の主要因のひとつとして挙げられます。

当レポートでは、南北アメリカ、欧州・中東・アフリカ、アジア太平洋地域におけるバイオシミラー市場を調査しており、世界市場の現況と成長の見通し、主要ベンダーの分析などを、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • 米国
  • 欧州
  • 日本
  • インド
  • 中国
  • ファイブフォース分析

第7章 アプリケーション別の市場区分

第8章 地理区分

  • アジア太平洋地域
  • 欧州・中東・アフリカ地域
  • 南北アメリカ

第9章 購入基準

第10章 市場成長因子

第11章 成長因子とその影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー
    • 競合分析
      • 米国
      • 欧州
      • 日本
      • インド
      • 中国

第17章 特許満了

第18章 主要ベンダーの分析

  • Biocon Ltd.
  • Celltrion Inc.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Hospira Inc.
  • Intas Pharmaceuticals Ltd.
  • Mylan Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • 3SBio Inc.

第19章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

TechNavio's analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market.

TechNavio's report, the Global Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Biocon Ltd., Hospira Inc., Mylan Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and Celltrion Inc.

Other vendors mentioned in the report are Actavis plc, Amgen Inc., AstraZeneca plc, Baxter International Inc., Biogen Idec Inc., Bioton S.A., Boehringer Ingelheim GmbH, Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Emcure Pharmaceuticals Ltd., GE Healthcare Ltd., GeneScience Pharmaceuticals Co. Ltd., GlaxoSmithKline plc, JCR Pharmaceuticals Co. Ltd., iBio Inc., LG Life Sciences Co. Ltd., Merck & Co. Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Samsung Biologics Co. Ltd., Sanofi S.A., and Wockhardt Ltd.

Key questions answered in this report:

  • What will the market size be in 2016/2018 and what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Biosimilars Market in the US
    • 06.3.1. Market Size and Forecast
  • 06.4. Biosimilars Market in Europe
    • 06.4.1. Market Size and Forecast
  • 06.5. Biosimilars Market in Japan
    • 06.5.1. Market Size and Forecast
  • 06.6. Biosimilars Market in India
    • 06.6.1. Market Size and Forecast
  • 06.7. Biosimilars Market in China
    • 06.7.1. Market Size and Forecast
  • 06.8. Five Forces Analysis

07. Market Segmentation by Application

08. Geographical Segmentation

  • 08.1. Biosimilars Market in the APAC Region
    • 08.1.1. Market Size and Forecast
  • 08.2. Biosimilars Market in the EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. Biosimilars Market in the Americas
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors
    • 16.3.1. Competitive Analysis in the US
    • 16.3.2. Competitive Analysis in Europe
    • 16.3.3. Competitive Analysis in Japan
    • 16.3.4. Competitive Analysis in India
    • 16.3.5. Competitive Analysis in China

17. Patent Expiries

18. Key Vendor Analysis

  • 18.1. Biocon Ltd.
    • 18.1.1. Business Overview
    • 18.1.2. Business Segmentation
    • 18.1.3. Key Information
    • 18.1.4. SWOT Analysis
  • 18.2. Celltrion Inc.
    • 18.2.1. Business Overview
    • 18.2.2. Key Information
    • 18.2.3. SWOT Analysis
  • 18.3. Dr. Reddy's Laboratories Ltd.
    • 18.3.1. Business Overview
    • 18.3.2. Business Segmentation
    • 18.3.3. Key Information
    • 18.3.4. SWOT Analysis
  • 18.4. F. Hoffmann-La Roche Ltd.
    • 18.4.1. Business Overview
    • 18.4.2. Business Segmentation
    • 18.4.3. Key Information
    • 18.4.4. SWOT Analysis
  • 18.5. Hospira Inc.
    • 18.5.1. Business Overview
    • 18.5.2. Business Segmentation
    • 18.5.3. Key Information
    • 18.5.4. SWOT Analysis
  • 18.6. Intas Pharmaceuticals Ltd.
    • 18.6.1. Business Overview
    • 18.6.2. Key Information
    • 18.6.3. SWOT Analysis
  • 18.7. Mylan Inc.
    • 18.7.1. Business Overview
    • 18.7.2. Business Segmentation
    • 18.7.3. Key Information
    • 18.7.4. SWOT Analysis
  • 18.8. Novartis AG
    • 18.8.1. Business Overview
    • 18.8.2. Business Segmentation
    • 18.8.3. Key Information
    • 18.8.4. SWOT Analysis
  • 18.9. Teva Pharmaceutical Industries Ltd.
    • 18.9.1. Business Overview
    • 18.9.2. Business Segmentation
    • 18.9.3. Key Information
    • 18.9.4. SWOT Analysis
  • 18.11. 3SBio Inc.
    • 18.11.1. Business Overview
    • 18.11.2. Key Information
    • 18.11.3. SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Biosimilars Market 2013-2018 (US$ million)
  • Exhibit 3: Biosimilars Market in the US 2013-2018 (US$ million)
  • Exhibit 4: Biosimilars Market in Europe 2013-2018 (US$ million)
  • Exhibit 5: Biosimilars Market in Japan 2013-2018 (US$ million)
  • Exhibit 6: Biosimilars Market in India 2013-2018 (US$ million)
  • Exhibit 7: Biosimilars Market in China 2013-2018 (US$ million)
  • Exhibit 8: Global Biosimilars Market Segmentation by Application
  • Exhibit 9: Global Biosimilars Market by Geographical Segmentation 2013
  • Exhibit 10: Biosimilars Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 11: Biosimilars Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 12: Biosimilars Market in the Americas 2013-2018 (US$ million)
  • Exhibit 13: Global Biosimilars Market by Geographical Segmentation (US$ million)
  • Exhibit 14: Global Biosimilars Market by Geographical Segmentation
  • Exhibit 15: Comparison of YOY Growth Rates among various Geographies in the Global Biosimilars Market
  • Exhibit 16: Business Segmentation of Biocon Ltd.
  • Exhibit 17: Business Segmentation of Dr. Reddy's Laboratories Ltd.
  • Exhibit 18: Business Segmentation of F. Hoffmann-La Roche Ltd.
  • Exhibit 19: Business Segmentation of Hospira Inc.
  • Exhibit 20: Business Segmentation of Mylan Inc.
  • Exhibit 21: Business Segmentation of Novartis AG
  • Exhibit 22: Business Segmentation of Teva Pharmaceutical Industries Ltd.
Back to Top